BioCentury
ARTICLE | Company News

Bio-Rad Laboratories, MorphoSys deal

January 21, 2013 8:00 AM UTC

MorphoSys completed the sale of its AbD Serotec research and diagnostic antibody division to Bio-Rad for about €53 million ($70.8 million) (see BioCentury, Dec. 24, 2012). ...